NCT00262847 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 625
- group Id
- BG001
- value
- 625
- group Id
- BG002
- value
- 623
- group Id
- BG003
- value
- 1873
- units
- Participants
- groups
- description
- Control therapy: Cycles 1-6 received paclitaxel, 175 mg/m2 plus carboplatin AUC 6 plus placebo (starting in cycle 2) every 3 weeks. Cycles 7-22 received placebo every 3 weeks.
- id
- BG000
- title
- Arm I (Placebo, Paclitaxel, Carboplatin)
- description
- Bevacizumab-initiation therapy: Cycles 1-6 received paclitaxel, 175 mg/m2 plus carboplatin AUC 6 plus bevacizumab, 15 mg/kg (starting in cycle 2) every 3 weeks. Cycles 7-22 received placebo every 3 weeks.
- id
- BG001
- title
- Arm II (Placebo, Paclitaxel, Carboplatin, Bevacizumab)
- description
- Bevacizumab-throughout therapy: Cycles 1-6 received paclitaxel, 175 mg/m2 plus carboplatin AUC 6 plus bevacizumab, 15 mg/kg (starting in cycle 2) every 3 weeks. Cycles 7-22 received bevacizumab, 15 mg/kg every 3 weeks.
- id
- BG002
- title
- Arm III (Paclitaxel, Carboplatin, Bevacizumab)
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.9
- value
- 59.3
- group Id
- BG001
- spread
- 10.3
- value
- 60.1
- group Id
- BG002
- spread
- 10.6
- value
- 59.7
- group Id
- BG003
- spread
- 10.6
- value
- 59.7
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 625
- group Id
- BG001
- value
- 625
- group Id
- BG002
- value
- 623
- group Id
- BG003
- value
- 1873
- title
- Female
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 526
- group Id
- BG001
- value
- 519
- group Id
- BG002
- value
- 521
- group Id
- BG003
- value
- 1566
- title
- Non-Hispanic white
- categories
- measurements
- group Id
- BG000
- value
- 41
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 39
- group Id
- BG003
- value
- 117
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 25
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 27
- group Id
- BG003
- value
- 80
- title
- Non-Hispanic black
- categories
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 25
- group Id
- BG003
- value
- 74
- title
- Hispanic
- categories
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 11
- group Id
- BG003
- value
- 36
- title
- Other or unspecified
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participant
- classes
- categories
- measurements
- group Id
- BG000
- value
- 596
- group Id
- BG001
- value
- 596
- group Id
- BG002
- value
- 599
- group Id
- BG003
- value
- 1791
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 9
- title
- Canada
- categories
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 45
- title
- Japan
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 28
- title
- Korea, Republic of
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 311
- group Id
- BG001
- value
- 315
- group Id
- BG002
- value
- 305
- group Id
- BG003
- value
- 931
- title
- 0 - fully active
- categories
- measurements
- group Id
- BG000
- value
- 272
- group Id
- BG001
- value
- 270
- group Id
- BG002
- value
- 267
- group Id
- BG003
- value
- 809
- title
- 1 - restricted strenuous activity, ambulatory
- categories
- measurements
- group Id
- BG000
- value
- 42
- group Id
- BG001
- value
- 40
- group Id
- BG002
- value
- 51
- group Id
- BG003
- value
- 133
- title
- 2 - ambulatory, difficulty walking
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- 3 - limited self-care, partly confined to bed
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- 4 - completely disabled, no self-care
- description
- 5-point, ordinal scale specifying patient's ability to perform activities from 0(fully active) to 4(completely disabled, no self-care).
- param Type
- NUMBER
- title
- Gynecologic Oncology Group (GOG) Performance Status
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- 1-limited to ovaries
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- 1A-1 ovary involved, no ascites
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- 1B-both ovaries involved, no ascites
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- 1C-disease with capsules ruptured or ascites
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- 2-disease with pelvic extension
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- 2A-disease with extension to uterus and or tubes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- 2B-disease with extension to other pelvic tissues
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- 2C-disease with capsules ruptured or ascites
- categories
- measurements
- group Id
- BG000
- value
- 218
- group Id
- BG001
- value
- 205
- group Id
- BG002
- value
- 216
- group Id
- BG003
- value
- 639
- title
- 3-disease w/ macroscopic implants outside pelvis
- categories
- measurements
- group Id
- BG000
- value
- 254
- group Id
- BG001
- value
- 256
- group Id
- BG002
- value
- 242
- group Id
- BG003
- value
- 752
- title
- 3-disease w/ implants > 1 cm outside pelvis
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- 3A-disease w/ microscopic implants, negative nodes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- 3B-disease w/ abdominal implants <2cm, neg nodes
- description
- Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)
- param Type
- NUMBER
- title
- International Federation of Gynecologic and Obstetrics (FIGO) Stage
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 541
- group Id
- BG001
- value
- 519
- group Id
- BG002
- value
- 524
- group Id
- BG003
- value
- 1584
- title
- Serous adenocarcinoma
- categories
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 24
- group Id
- BG003
- value
- 59
- title
- Endometrioid
- categories
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 20
- group Id
- BG003
- value
- 55
- title
- Clear cell
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 19
- title
- Mucinous
- categories
- measurements
- group Id
- BG000
- value
- 45
- group Id
- BG001
- value
- 64
- group Id
- BG002
- value
- 47
- group Id
- BG003
- value
- 156
- title
- Other or not specified
- description
- Histologic(cell) type was obtained from the central GOG Pathology Committee review updated in September 2010.
- param Type
- NUMBER
- title
- Histologic Type
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 445
- group Id
- BG001
- value
- 465
- group Id
- BG002
- value
- 460
- group Id
- BG003
- value
- 1370
- title
- 3
- categories
- measurements
- group Id
- BG000
- value
- 102
- group Id
- BG001
- value
- 86
- group Id
- BG002
- value
- 97
- group Id
- BG003
- value
- 285
- title
- 2
- categories
- measurements
- group Id
- BG000
- value
- 36
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 18
- group Id
- BG003
- value
- 82
- title
- 1
- categories
- measurements
- group Id
- BG000
- value
- 42
- group Id
- BG001
- value
- 46
- group Id
- BG002
- value
- 48
- group Id
- BG003
- value
- 136
- title
- Not graded
- description
- Tumor grade was obtained from the central GOG Pathology Committee review updated in September 2010. All clear-cell tumors were classified as grade 3.
- param Type
- NUMBER
- title
- Tumor Grade
- unit Of Measure
- participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 625
- group Id
- BG001
- value
- 625
- group Id
- BG002
- value
- 623
- group Id
- BG003
- value
- 1873
- units
- Participants
- groups
- description
- Control therapy: Cycles 1-6 received paclitaxel, 175 mg/m2 plus carboplatin AUC 6 plus placebo (starting in cycle 2) every 3 weeks. Cycles 7-22 received placebo every 3 weeks.
- id
- BG000
- title
- Arm I (Placebo, Paclitaxel, Carboplatin)
- description
- Bevacizumab-initiation therapy: Cycles 1-6 received paclitaxel, 175 mg/m2 plus carboplatin AUC 6 plus bevacizumab, 15 mg/kg (starting in cycle 2) every 3 weeks. Cycles 7-22 received placebo every 3 weeks.
- id
- BG001
- title
- Arm II (Placebo, Paclitaxel, Carboplatin, Bevacizumab)
- description
- Bevacizumab-throughout therapy: Cycles 1-6 received paclitaxel, 175 mg/m2 plus carboplatin AUC 6 plus bevacizumab, 15 mg/kg (starting in cycle 2) every 3 weeks. Cycles 7-22 received bevacizumab, 15 mg/kg every 3 weeks.
- id
- BG002
- title
- Arm III (Paclitaxel, Carboplatin, Bevacizumab)
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.9
- value
- 59.3
- group Id
- BG001
- spread
- 10.3
- value
- 60.1
- group Id
- BG002
- spread
- 10.6
- value
- 59.7
- group Id
- BG003
- spread
- 10.6
- value
- 59.7
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 625
- group Id
- BG001
- value
- 625
- group Id
- BG002
- value
- 623
- group Id
- BG003
- value
- 1873
- title
- Female
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 526
- group Id
- BG001
- value
- 519
- group Id
- BG002
- value
- 521
- group Id
- BG003
- value
- 1566
- title
- Non-Hispanic white
- categories
- measurements
- group Id
- BG000
- value
- 41
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 39
- group Id
- BG003
- value
- 117
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 25
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 27
- group Id
- BG003
- value
- 80
- title
- Non-Hispanic black
- categories
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 25
- group Id
- BG003
- value
- 74
- title
- Hispanic
- categories
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 11
- group Id
- BG003
- value
- 36
- title
- Other or unspecified
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participant
- classes
- categories
- measurements
- group Id
- BG000
- value
- 596
- group Id
- BG001
- value
- 596
- group Id
- BG002
- value
- 599
- group Id
- BG003
- value
- 1791
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 9
- title
- Canada
- categories
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 45
- title
- Japan
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 28
- title
- Korea, Republic of
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 311
- group Id
- BG001
- value
- 315
- group Id
- BG002
- value
- 305
- group Id
- BG003
- value
- 931
- title
- 0 - fully active
- categories
- measurements
- group Id
- BG000
- value
- 272
- group Id
- BG001
- value
- 270
- group Id
- BG002
- value
- 267
- group Id
- BG003
- value
- 809
- title
- 1 - restricted strenuous activity, ambulatory
- categories
- measurements
- group Id
- BG000
- value
- 42
- group Id
- BG001
- value
- 40
- group Id
- BG002
- value
- 51
- group Id
- BG003
- value
- 133
- title
- 2 - ambulatory, difficulty walking
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- 3 - limited self-care, partly confined to bed
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- 4 - completely disabled, no self-care
- description
- 5-point, ordinal scale specifying patient's ability to perform activities from 0(fully active) to 4(completely disabled, no self-care).
- param Type
- NUMBER
- title
- Gynecologic Oncology Group (GOG) Performance Status
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- 1-limited to ovaries
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- 1A-1 ovary involved, no ascites
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- 1B-both ovaries involved, no ascites
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- 1C-disease with capsules ruptured or ascites
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- 2-disease with pelvic extension
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- 2A-disease with extension to uterus and or tubes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- 2B-disease with extension to other pelvic tissues
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- 2C-disease with capsules ruptured or ascites
- categories
- measurements
- group Id
- BG000
- value
- 218
- group Id
- BG001
- value
- 205
- group Id
- BG002
- value
- 216
- group Id
- BG003
- value
- 639
- title
- 3-disease w/ macroscopic implants outside pelvis
- categories
- measurements
- group Id
- BG000
- value
- 254
- group Id
- BG001
- value
- 256
- group Id
- BG002
- value
- 242
- group Id
- BG003
- value
- 752
- title
- 3-disease w/ implants > 1 cm outside pelvis
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- 3A-disease w/ microscopic implants, negative nodes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- 3B-disease w/ abdominal implants <2cm, neg nodes
- description
- Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)
- param Type
- NUMBER
- title
- International Federation of Gynecologic and Obstetrics (FIGO) Stage
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 541
- group Id
- BG001
- value
- 519
- group Id
- BG002
- value
- 524
- group Id
- BG003
- value
- 1584
- title
- Serous adenocarcinoma
- categories
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 24
- group Id
- BG003
- value
- 59
- title
- Endometrioid
- categories
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 20
- group Id
- BG003
- value
- 55
- title
- Clear cell
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 19
- title
- Mucinous
- categories
- measurements
- group Id
- BG000
- value
- 45
- group Id
- BG001
- value
- 64
- group Id
- BG002
- value
- 47
- group Id
- BG003
- value
- 156
- title
- Other or not specified
- description
- Histologic(cell) type was obtained from the central GOG Pathology Committee review updated in September 2010.
- param Type
- NUMBER
- title
- Histologic Type
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 445
- group Id
- BG001
- value
- 465
- group Id
- BG002
- value
- 460
- group Id
- BG003
- value
- 1370
- title
- 3
- categories
- measurements
- group Id
- BG000
- value
- 102
- group Id
- BG001
- value
- 86
- group Id
- BG002
- value
- 97
- group Id
- BG003
- value
- 285
- title
- 2
- categories
- measurements
- group Id
- BG000
- value
- 36
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 18
- group Id
- BG003
- value
- 82
- title
- 1
- categories
- measurements
- group Id
- BG000
- value
- 42
- group Id
- BG001
- value
- 46
- group Id
- BG002
- value
- 48
- group Id
- BG003
- value
- 136
- title
- Not graded
- description
- Tumor grade was obtained from the central GOG Pathology Committee review updated in September 2010. All clear-cell tumors were classified as grade 3.
- param Type
- NUMBER
- title
- Tumor Grade
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle